Annonce • Jul 22
Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 200 million worth of its shares. Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 57.21 per share. The purpose of the program is to maintain company's value and shareholders' interest, employee shareholding plan or as equity incentive. The company will use CNY 40 million worth of shares for employee shareholding plan or as equity incentives and CNY 160 million worth of shares to maintain company's value and shareholders' interest. The program will be valid for 3 months from directorates' approval for maintaining company's value and shareholders' interest and for 12 months from directorates' approval date for employee shareholding plan or as equity incentive. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥30.91, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 13% over the past three years. Annonce • Jun 30
Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026 Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026 Declared Dividend • Jun 26
Dividend reduced to CN¥0.083 Dividend of CN¥0.083 is 43% lower than last year. Ex-date: 30th June 2026 Payment date: 30th June 2026 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (14% earnings payout ratio) and cash flows (89% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 182% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Jun 04
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years. Board Change • May 20
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Yonghong Yang was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Annonce • Apr 30
Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026 Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu China Annonce • Mar 30
Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Annonce • Dec 26
Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026 Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026 Annonce • Sep 30
Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025 Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025 Annonce • Jun 30
Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Annonce • Apr 30
Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025 Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025, at 09:00 China Standard Time. Location: No. 113, Qinglongshan Road, New District, Zhenjiang, Jiangsu China Annonce • Mar 28
Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025 Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025 Annonce • Jan 11
Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 100 million worth of its shares. Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 63.47 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months. Annonce • Dec 27
Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2025 Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 30, 2025 New Risk • Nov 14
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Paying a dividend despite having no free cash flows. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 34% After last week's 34% share price gain to CN¥38.47, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 30% over the past year. Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 3Q 2023). Revenue: CN¥393.7m (down 5.6% from 3Q 2023). Net income: CN¥67.1m (down 6.3% from 3Q 2023). Profit margin: 17% (in line with 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥26.15, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 2.5% over the past year. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.7% average weekly change). Annonce • Sep 30
Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to CN¥24.48, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 5.0% over the past year. Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.14 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥339.5m (down 6.3% from 2Q 2023). Net income: CN¥61.7m (up 23% from 2Q 2023). Profit margin: 18% (up from 14% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Annonce • Jun 28
Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024 Annonce • Apr 29
Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024 Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 09:00 China Standard Time. Location: The Company's Meeting Room, Zhenjiang, Jiangsu China Reported Earnings • Apr 27
Full year 2023 earnings released Full year 2023 results: Revenue: CN¥1.40b (down 24% from FY 2022). Net income: CN¥297.2m (down 30% from FY 2022). Profit margin: 21% (down from 23% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥24.76, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year. Annonce • Mar 29
Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to CN¥19.62, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years. Valuation Update With 7 Day Price Move • Jan 22
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥22.20, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years. New Risk • Jan 17
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (26% accrual ratio). Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.36 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.36 in 3Q 2022). Revenue: CN¥417.3m (down 17% from 3Q 2022). Net income: CN¥71.6m (down 42% from 3Q 2022). Profit margin: 17% (down from 25% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. New Risk • Oct 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change). Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥29.44, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 1.8% over the past three years. Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.30 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.30 in 2Q 2022). Revenue: CN¥362.3m (down 21% from 2Q 2022). Net income: CN¥50.1m (down 52% from 2Q 2022). Profit margin: 14% (down from 23% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Annonce • Jun 28
Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023 Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023 New Risk • Jun 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change). Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to CN¥53.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years. Reported Earnings • Apr 21
First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 21
First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 25
Full year 2022 earnings released: EPS: CN¥1.77 (vs CN¥1.28 in FY 2021) Full year 2022 results: EPS: CN¥1.77 (up from CN¥1.28 in FY 2021). Revenue: CN¥1.84b (up 39% from FY 2021). Net income: CN¥411.0m (up 39% from FY 2021). Profit margin: 22% (in line with FY 2021). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥83.82, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Xinxin Wang was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 05
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥110, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 294% over the past three years. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.36 in 3Q 2021). Revenue: CN¥501.1m (up 29% from 3Q 2021). Net income: CN¥123.7m (up 49% from 3Q 2021). Profit margin: 25% (up from 21% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Reported Earnings • Aug 26
Second quarter 2022 earnings released: EPS: CN¥0.45 (vs CN¥0.29 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.45 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥460.8m (up 52% from 2Q 2021). Net income: CN¥104.2m (up 55% from 2Q 2021). Profit margin: 23% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 85%, compared to a 42% growth forecast for the Chemicals industry in China. Board Change • Jun 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). Director Ge Yan was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.